GENETICS & DISEASE
Stem cells A way to maintain pluripotency
Fibroblast growth factor-2 keeps stems cells in their undifferentiated state by activating Wnt signaling
Human embryonic stem cells (hESCs) are derived from blasto- cysts at the earliest stages of embryonic development. They can divide indefinitely and differentiate into any cell type found in the body — a property known as pluripotency. Until now, the mechanisms underlying pluripotency have been far from clear. Now, a team of researchers led by Andre Choo and Simon Cool at the A*STAR Bioprocessing Technology Institute and Institute of Medical Biology, respectively, has elucidated the fibroblast growth factor (FGF)-2 signaling pathway that maintains human embryonic stem cells (hESCs) in their undifferentiated state1
. Previous studies have shown that FGF-2 maintains cultured
hESCs in their undifferentiated state by activating the FGF receptor (FGFR), which in turn activates the mitogen activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3-K) signaling pathways. Choo, Cool and co-workers found that FGF-2 induces rapid
and prolonged activation of the MAPK and PI3-K signal- ing pathways by key phosphorylating components. They also found that PI3-K signaling pathway plays a more critical role in pluripotency; inhibition of this pathway results in the down- regulation of genes associated with pluripotency. Further experiments revealed that PI3-K activates a key sig- naling pathway known as Wnt signaling, which then inactivates an enzyme called GSK3β. This causes a protein called β-catenin to move from the cytoplasm into the nucleus, where it regulates a number of genes that are required for pluripotency. The researchers performed the same experiments in induced
pluripotent stem cells (iPSCs) and obtained similar results. iPSCs are cells derived from differentiated adult cells, which are forced back into their undifferentiated state by altering the level of pluripotency associated genes expression. Because of their ability to differentiate into any cell type in the human body, both hESCs and iPSCs hold enormous potential for the treatment of a wide variety of diseases and conditions, including heart and Parkinson’s diseases. Differentiated hESCs and iPSCs are also useful for the toxicology screening of newly developed drugs. The new findings are significant because they enable scientists
32
to understand the intricate signaling mechanisms controlling hESC and iPSC pluripotency. Understanding the mechanism behind pluripotency could
lead to improved methods to expand stem cell populations in their undifferentiated state, and help in the design of strate- gies to induce stem cells to initiate differentiation into specific lineages for use in therapeutic applications.
■
1. Ding, V. M. Y. et al. FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3β signaling. Journal of Cellular Physiology 225, 417–428 (2010).
A*STAR RESEARCH OCTOBER 2011– MARCH 2012
©
iStockphoto.com/Henrik Jonsson
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96